Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
about
Heterodimerization of alpha 2A- and beta 1-adrenergic receptorsAirway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complexEvidence for a single heptahelical domain being turned on upon activation of a dimeric GPCRHeterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patternsCrystal structure of the β2 adrenergic receptor-Gs protein complexIdentification of a serotonin/glutamate receptor complex implicated in psychosisThe structural basis of arrestin-mediated regulation of G-protein-coupled receptorsThe receptor concept: pharmacology's big ideaMetaphors, naming and new signaling paradigms by G-protein-coupled receptorsComputational approaches for modeling GPCR dimerizationFluorescent approaches for understanding interactions of ligands with G protein coupled receptorsCrystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal stateHeterotrimeric G proteins precouple with G protein-coupled receptors in living cells.Oligomerization of the yeast alpha-factor receptor: implications for dominant negative effects of mutant receptors.Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR FunctionDimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulationThe neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesHeterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporterCrosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integrationFormation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesiaEffects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulationA cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G proteinDimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissuesmu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisA bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptorsDirect observation of individual KCNQ1 potassium channels reveals their distinctive diffusive behavior.Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organizationSegregation of family A G protein-coupled receptor protomers in the plasma membraneProtein interaction quantified in vivo by spectrally resolved fluorescence resonance energy transferRandom mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor.Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.Comparison between whole distribution- and average-based approaches to the determination of fluorescence resonance energy transfer efficiency in ensembles of proteins in living cellsCharacterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation.A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transferSeven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Beyond desensitization: physiological relevance of arrestin-dependent signaling.Structure and function of G protein-coupled receptors using NMR spectroscopy.Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.
P2860
Q24292697-87B7EE61-140A-4203-A69C-864735DF2CDCQ24545426-FC94213F-3152-448B-8881-5F8B594CD472Q24556662-33D682BA-29A9-48B1-B92F-2FFF7FA37D36Q24618881-A4E01AC5-5631-4FE4-A0C3-D12CEE380B63Q24635327-DC30A498-3A3B-4465-8DBD-D52A2882AB52Q24655484-73F34FB8-9EB9-4767-B34C-E0958D5F781BQ24657537-EBBB8912-F0BF-4218-B4D1-FB21BFABAD26Q24670242-63B96E32-DFD9-406E-B3C6-2F80C19349B3Q26991511-FDEB7837-468B-479E-A392-67EDCE03114EQ27001137-413ED659-2BD9-4C11-B196-F09D7B3278D9Q27004213-B3972A59-1532-4241-966D-E4244FC9B1B8Q27676608-A7E95B20-DB67-499C-83C8-674BEC57DCF3Q27863906-04C06993-74D7-47CD-8C77-B0A5752FCDFEQ27929513-0AB3E906-ABB3-4675-9118-EBFA9BB494AFQ28072820-57EAB73F-C8FF-4F83-B43E-2A170AD639F4Q28218765-7C370C27-3F5B-4EF7-9E77-61322FAB6723Q28289714-F43760BF-D29B-478D-A85C-790B8C9F6E2AQ28509995-F6B02193-18D6-4464-91AC-C05C76295216Q28564967-1FCB7D80-0E2C-4700-B4E0-4753800D3D59Q28568886-437EF104-F68F-45C4-8DB9-9634946901D2Q28576205-A89F216F-EE57-46D3-A722-7617B61D42AEQ28580583-1649F13A-3135-491C-8642-F3D1E54C8B69Q28582095-86D86B50-0778-4CA8-B084-26E314DA99A1Q28591542-2D628652-5758-4D93-9884-F66355BF6165Q28822182-638E1ABA-F883-444A-B598-46BAC6B2888EQ30493179-8C87EB40-A858-41D8-B63A-FCEC5CC9DFAEQ30532359-3E2BAA8F-1EA5-47F1-969F-8283715AAA85Q30561102-DCB91408-3FE4-437B-A658-3267AD2FD1DCQ31110128-013DFBBC-3384-4235-9BE7-6FACFF291791Q31133166-E81C98A1-869E-463E-B50C-8C87A0DDAC11Q33112683-77B72B3A-FC39-4737-A98C-28F74C3FACFEQ33581599-8EDF7905-5213-46D0-93AC-3B59B4D1E431Q33642043-EF2661FA-4AB2-4A17-B13F-7D7BEC22680DQ33742756-169E257E-B0A8-487E-85AF-80D2CD4AC293Q33880430-2157FD6E-2330-4A8C-8C51-2D5A7EA5D079Q33890786-B17955ED-317F-4FD3-B044-C4ACB9E6067DQ33890802-2F5F1EFA-BDCE-4F52-9B69-E4BE1BDE52C1Q34008693-A2C5CE2E-1CE0-4351-9593-3980369D25EDQ34051430-524D4C7D-06F3-4F5E-AF10-DCE624BAAB9EQ34061067-B3709707-4240-4021-AAC2-FA565B190533
P2860
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@ast
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@en
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@nl
type
label
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@ast
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@en
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@nl
prefLabel
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@ast
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@en
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@nl
P1476
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
@en
P2093
Ali Salahpour
P304
P356
10.1146/ANNUREV.PHARMTOX.42.091701.082314
P577
2002-01-01T00:00:00Z